PT-141

PT-141 (bremelanotide) 10 mg is offered by SARMs Revolution Lab for laboratory research and analytical work in Canada. This page separates the commercial research material from the prescription-drug evidence often associated with the bremelanotide name.

PT-141 10 mg research product information

Batch identity, concentration and analytical documentation should be reviewed separately. A product name alone does not establish pharmaceutical equivalence, clinical efficacy or authorization for human use.

What is PT-141 (bremelanotide)?

Bremelanotide is a synthetic cyclic peptide derived from melanocortin research. Published literature describes activity at several melanocortin receptor subtypes, with MC4R receiving particular attention in neurobiological models. These receptors participate in signalling networks studied in the central nervous system and other tissues.

A peer-reviewed review of bremelanotide discusses melanocortin signalling and possible downstream involvement of dopamine in specific brain regions. Those clinical and pharmacological findings concern a regulated drug formulation and controlled study conditions; they should not be treated as proof about an independently sold 10 mg research vial.

How is PT-141 studied in peptide research?

Research questions include receptor selectivity, ligand-receptor binding, downstream signalling and behavioural pharmacology. Experimental design matters: cell systems, animal models and controlled clinical studies answer different questions and cannot be combined as if they provide the same level of evidence.

The available human literature also reports adverse events and limitations. Scientific information therefore needs to present both mechanism and uncertainty, rather than turning a research finding into a guaranteed outcome or a self-administration claim.

PT-141 research and regulatory context in Canada

A drug approval in another country does not automatically authorize a research product in Canada. Health Canada has warned about unauthorized injectable peptides sold online and specifically notes that a “For Research Use Only” label does not remove regulatory requirements. Researchers should distinguish a chemical research material, an authorized medicine and a compounded preparation.

This page does not provide diagnosis, treatment, dosage, reconstitution, injection or self-administration instructions.

PT-141 10 mg frequently asked questions

What quantity is supplied in the SRL PT-141 vial?

The product listing identifies one 10 mg vial. Review the label and any batch-specific analytical documentation supplied with the product.

Is PT-141 the same as an authorized bremelanotide medicine?

No equivalence should be assumed. Published drug evidence concerns defined formulations, manufacturing controls and regulated clinical use. A research vial must be evaluated on its own identity and documentation.

What is the main research target associated with PT-141?

The literature primarily discusses melanocortin receptor agonism, particularly pathways involving MC4R, while also recognizing activity at other receptor subtypes.

Does this page provide a PT-141 dose or protocol?

No. It provides product specifications and scientific context only. It does not provide dosing, reconstitution or administration instructions.

How should the vial be stored for laboratory inventory?

Follow the product label and batch documentation. Keep the sealed research material protected from heat, moisture and direct light unless the accompanying documentation specifies different conditions.

Where can researchers compare related products?

See the SRL peptide research category for other laboratory materials.

Scientific and regulatory references

• Pfaus JG et al. The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder. 2021.
• Early clinical pharmacology research on melanocortin agonists and sexual response.
• Health Canada warning concerning unauthorized injectable peptide drugs.

Research-use notice: PT-141 10 mg is offered strictly for laboratory research and analytical work. It is not intended for human consumption, self-administration, diagnosis, treatment or veterinary use.